Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1582-1583
DOI: 10.1111/apt.70687 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 15.04.2026. Verfasst von Anupam Kumar Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Gastroenterology, All India Institute of Medical Science, Jodhpur, Rajasthan, India.
ORCID-Profile: Chhagan Lal Birda
Zitieren
APA
Singh, A. K., & Birda, C. L. (2026). Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(11), 1582-1583. https://doi.org/10.1111/apt.70687
Vancouver
Singh AK, Birda CL. Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(11):1582-1583. doi:10.1111/apt.70687
BibTeX
@article{Singh2026,
author = {Singh, Anupam Kumar and Birda, Chhagan Lal},
title = {Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {11},
pages = {1582--1583},
doi = {10.1111/apt.70687}
}
EUVIMED